Clonal evolution in myelodysplastic syndromes. [electronic resource]
Producer: 20181115Description: 15099 p. digitalISSN:- 2041-1723
- Aged
- Angiogenesis Inhibitors -- therapeutic use
- Biomarkers, Tumor -- genetics
- Bone Marrow Cells -- drug effects
- Clonal Evolution -- drug effects
- Disease Management
- Disease Progression
- Drug Resistance, Neoplasm -- genetics
- Female
- Follow-Up Studies
- GTP Phosphohydrolases -- genetics
- Gene Expression Regulation, Neoplastic
- Humans
- Lenalidomide
- Male
- Membrane Proteins -- genetics
- Middle Aged
- Monitoring, Physiologic
- Mutation
- Myelodysplastic Syndromes -- drug therapy
- Proto-Oncogene Proteins p21(ras) -- genetics
- Thalidomide -- analogs & derivatives
- Tumor Suppressor Protein p53 -- genetics
- Exome Sequencing
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.